Patent details

Basic Information

Publication number:

EP2935268

PCT Application Number:

EP2013077705

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138149398

PCT Publication Number:

WO2014096368

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF

French Title of Invention:

PYRROLOBENZODIAZÉPINES ET CONJUGUÉS ASSOCIÉS

German Title of Invention:

PYRROLOBENZODIAZEPINE UND KONJUGATE DAVON

SPC Number:

Dates

Filing date:

20/12/2013

Grant date:

22/11/2017

EP Publication Date:

28/10/2015

PCT Publication Date:

26/06/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/11/2017

EP B1 Publication Date:

22/11/2017

EP B2 Publication Date:

17/02/2021

EP B3 Publication Date:

Lapsed date:

20/12/2017

Expiration date:

20/12/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/02/2021

 

 

Name:

MedImmune Limited

Address:

Milstein Building Granta Park, Cambridge CB21 6GH, United Kingdom (GB)

Inventor

Name:

HOWARD, Philip Wilson

Address:

United Kingdom (GB)

Priority

Priority Number:

201261740592 P

Priority Date:

21/12/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 47/22; A61P 35/00; C07D 487/04;

Publication

European Patent Bulletin

1

Issue number:

201747

Publication date:

22/11/2017

Description:

Grant (B1)

2

Issue number:

202107

Publication date:

17/02/2021

Description:

Patent maintained (B2 publication)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/04/2018	Outgoing Correspondence	1